Loading: 100%
PerkinElmer logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Waltham, United States of AmericaWaltham, United States of Americano data available
Employees 8,000 (as per H2 2017)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker PKIno data available
Financial year endsFY ends End of Januaryno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1745,052,560,067,575,0
datesClosing price (adj.)
13.10.201771.39
11.10.201771.50
04.10.201770.13
27.09.201768.39
20.09.201768.92
13.09.201768.46
06.09.201767.52
30.08.201766.12
23.08.201764.97
16.08.201764.58
09.08.201764.19
02.08.201766.65
26.07.201766.02
19.07.201769.32
12.07.201768.85
05.07.201768.11
27.06.201767.42
20.06.201767.96
13.06.201764.00
06.06.201764.62
30.05.201762.83
23.05.201761.94
16.05.201762.42
09.05.201762.44
02.05.201759.52
25.04.201758.53
18.04.201757.48
11.04.201757.35
04.04.201757.28
28.03.201757.77
21.03.201757.09
14.03.201755.64
07.03.201753.91
28.02.201754.09
21.02.201755.48
14.02.201754.23
07.02.201752.52
31.01.201753.02
24.01.201751.40
17.01.201752.69
10.01.201753.10
03.01.201752.75
27.12.201652.44
19.12.201653.20
12.12.201653.32
05.12.201650.92
28.11.201650.71
21.11.201650.35
14.11.201650.04
07.11.201651.63
31.10.201650.66
24.10.201652.84
17.10.201651.57
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
71.39n/a
Market Capitalisation
in million USD
7,867n/a
Enterprise Value
in million USD
8,342n/a
Common Shares Outstanding
as per Jul 2, 2017
110,196,000n/a
Preferred Shares Outstanding
as per Jul 2, 2017
n/a
Average Basic Shares Outstanding
TTM
n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
PerkinElmer Inc is a diagnostics company providing instruments, consumables, and services to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 616n/a
Receivables 440n/a
Total Current Assets 1,434n/a
PP&E 154n/a
Total Assets 4,605n/a
Accounts Payable 154n/a
Current Debt 2n/a
Total Current Liabilities 589n/a
Long-Term Debt 1,089n/a
Total Liabilities 2,166n/a
Total Equity 2,439n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.31n/a
Other Ratios
Current Ratio 243.3%n/a
Liabilities to Equity Ratio 88.8%n/a
Debt to Assets Ratio 23.7%n/a
Profit & Loss StatementP&L data quality: 18% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
1,660
1,551
1,702
1,919
2,105
2,158
2,070
2,105
2,116
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-926
-850
-943
-1,071
-1,144
-1,181
-1,135
-1,141
-1,102
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
734
701
759
848
962
976
935
964
1,013
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-579
-567
-582
-740
-759
-714
-756
-700
-725
Selling, General & Administrative
-486
-477
-487
-624
-627
-582
-648
-587
-601
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-93
-90
-95
-116
-132
-132
-108
-113
-124
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
154
134
177
108
202
262
178
264
288
Non-Operating Income (Loss)
44
16
-8
27
48
64
41
42
39
Interest Expense, net
44
16
-8
27
48
64
41
42
39
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
198
150
168
134
250
326
219
307
327
Abnormal Gains (Losses)
7
18
19
10
-49
34
13
14
5
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
205
168
187
145
201
360
233
320
332
Income Tax (Expense) Benefit, net
-13
-27
-27
-63
16
11
6
-20
-28
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
192
141
160
82
217
370
239
300
304
Net Extraordinary Gains (Losses)
36
15
445
-2
-3
-17
53
47
27
Discontinued Operations
36
15
445
-2
-3
-17
53
47
27
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
228
156
605
79
214
353
292
347
331
Minority Interest
0
0
0
0
0
0
0
0
0
Net Income
228
156
605
79
214
353
292
347
331
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
228
156
605
79
214
353
292
347
331
Remarks
restated on Mar 1, 2011 n/a
calculated values,
restated on Feb 28, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 24, 2015 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Balance SheetBS data quality: 84% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
180
420
142
171
173
175
238
359
Cash & Cash Equivalents
n/a
180
420
142
171
173
175
238
359
Short Term Investments
n/a
0
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
320
357
410
457
467
471
415
426
Accounts Receivable, Net
n/a
320
357
410
457
467
471
415
426
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
179
207
241
248
261
285
259
247
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
205
101
90
96
144
138
121
158
Prepaid Expenses
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
97
0
0
0
4
0
56
59
Miscellaneous Short Term Assets
n/a
109
101
90
96
140
138
64
99
Total Current Assets
n/a
884
1,085
883
972
1,045
1,069
1,033
1,190
Property, Plant & Equipment, Net
n/a
153
162
175
211
183
176
138
145
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
2
1
1
1
1
2
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
2,030
1,961
2,797
2,718
2,717
2,881
2,996
2,941
Intangible Assets
n/a
443
424
662
530
460
490
486
420
Goodwill
n/a
1,419
1,505
2,094
2,123
2,143
2,284
2,237
2,248
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
125
0
0
0
2
0
75
68
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
44
32
41
66
112
107
198
205
Total Noncurrent Assets
n/a
2,186
2,124
2,973
2,930
2,902
3,059
3,133
3,087
Total Assets
n/a
3,070
3,209
3,856
3,902
3,947
4,128
4,166
4,277
Liabilities and owners' equity
Payables & Accruals
n/a
430 429504000
484 484080000
583 583295000
557 556969000
571 570559000
577 576974000
523 523314000
568 567733000
Accounts Payable
n/a
134 133792000
161 161042000
173 173153000
169 168943000
167 166881000
174 173953000
141 140980000
168 168033000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
296 295712000
323 323038000
410 410142000
388 388026000
404 403678000
403 403021000
382 382334000
400 399700000
Short Term Debt
n/a
0 146000
2 2255000
0 0
2 1772000
3 2624000
1 1075000
1 1123000
1 1172000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
68 67554000
29 28867000
15 15387000
22 22359000
30 29613000
19 19261000
37 37048000
34 34450000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
53 53204000
6 6256000
1 1429000
1 995000
3 3239000
2 2137000
20 20006000
27 26971000
Miscellaneous Short Term Liabilities
n/a
14 14350000
23 22611000
14 13958000
21 21364000
26 26374000
17 17124000
17 17042000
7 7479000
Total Current Liabilities
n/a
497 497204000
515 515202000
599 598682000
581 581100000
603 602796000
597 597310000
561 561485000
603 603355000
Long Term Debt
n/a
558 558197000
424 424000000
945 944908000
939 938824000
932 932104000
1,045 1045393000
1,012 1011762000
1,045 1045254000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
364 363905000
344 344353000
470 469835000
442 442026000
417 417325000
443 442771000
465 465490000
460 459544000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
364 363905000
344 344353000
470 469835000
442 442026000
417 417325000
443 442771000
465 465490000
460 459544000
Total Noncurrent Liabilities
n/a
922 922102000
768 768353000
1,415 1414743000
1,381 1380850000
1,349 1349429000
1,488 1488164000
1,477 1477252000
1,505 1504798000
Total Liabilities
n/a
1,419 1419306000
1,284 1283555000
2,013 2013425000
1,962 1961950000
1,952 1952225000
2,085 2085474000
2,039 2038737000
2,108 2108153000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
368 367622000
340 339728000
277 277447000
325 324646000
233 232532000
207 206757000
165 164966000
136 135747000
Common Stock
n/a
117 117023000
116 115715000
113 113157000
115 115036000
113 112626000
112 112481000
112 112034000
110 109617000
Additional Paid in Capital
n/a
251 250599000
224 224013000
164 164290000
210 209610000
120 119906000
94 94276000
53 52932000
26 26130000
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
1,289 1288586000
1,535 1534635000
1,511 1510683000
1,549 1548573000
1,684 1684364000
1,811 1810545000
1,991 1991431000
2,119 2118684000
Other Equity
n/a
-27 -27251000
51 51028000
54 54086000
67 66593000
78 77591000
25 24800000
-46 -45956000
-101 -100861000
Equity Before Minority Interest
n/a
1,629 1628957000
1,925 1925391000
1,842 1842216000
1,940 1939812000
1,994 1994487000
2,042 2042102000
2,110 2110441000
2,154 2153570000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
1,629 1628957000
1,925 1925391000
1,842 1842216000
1,940 1939812000
1,994 1994487000
2,042 2042102000
2,110 2110441000
2,154 2153570000
Total Liabilities & Equity
n/a
3,048 3048263000
3,209 3208946000
3,856 3855641000
3,902 3901762000
3,947 3946712000
4,128 4127576000
4,149 4149178000
4,262 4261723000
Remarks restated on n/a restated on Mar 1, 2011 n/a restated on Feb 28, 2012 n/a restated on Feb 26, 2013 n/a restated on Feb 25, 2014 n/a restated on Feb 24, 2015 n/a restated on Mar 1, 2016 n/a restated on Feb 28, 2017 n/a restated on Feb 28, 2017 n/a
Cash Flow StatementCF data quality: 84% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
91
73
139
1
71
174
130
189
216
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
77
81
89
111
125
127
110
105
100
Non-Cash Items
14
18
-4
146
84
-85
36
4
-10
Stock-Based Compensation
18
14
12
15
21
14
14
17
17
Deferred Income Taxes
-17
22
0
0
0
0
-33
-7
-7
Other Non-Cash Adjustments
12
-18
-16
131
63
-99
55
-6
-21
Change in Working Capital
-11
-45
-33
-25
-61
-29
-29
-35
19
(Increase) Decrease in Accounts Receivable
-6
-30
-38
-21
-45
-14
-12
4
-19
(Increase) Decrease in Inventories
-9
-4
-23
-2
-8
-14
-19
-28
7
Increase (Decrease) in Accounts Payable
5
-10
28
-2
-8
-1
3
-11
31
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
47
21
-3
-9
-2
1
34
23
27
Cash from Operating Activities
218
149
189
225
218
188
282
287
351
Change in Fixed Assets & Intangibles
-35
-26
-23
-30
-42
13
-25
-28
-32
Disposition of Fixed Assets & Intangibles
0
0
11
0
0
52
3
0
0
Disposition of Fixed Assets
0
0
11
0
0
52
3
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
-35
-26
-34
-31
-42
-39
-27
-28
-32
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
1
0
0
0
0
0
0
0
21
Net Cash from Divestitures
1
0
0
0
0
0
0
0
21
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
-85
-101
-151
-912
-40
-15
-271
-71
-89
Net Cash From Discontinued Operations (investing)
-16
-28
469
32
2
0
0
-1
-1
Cash from Investing Activities
-136
-154
295
-910
-80
-1
-296
-101
-101
Dividends Paid
-33
-33
-33
-32
-32
-32
-32
-32
-31
Cash From (Repayment of) Debt
-7
45
-141
521
-41
-11
119
-34
64
Cash From (Repayment of) Short Term Debt, net
-157
45
-141
24
-41
139
119
-34
-482
Cash From (Repayment of) Long Term Debt, net
150
0
0
497
0
-150
0
0
546
Repayments of Long Term Debt
150
0
0
0
0
-150
0
0
546
Cash From Long Term Debt
0
0
0
497
0
0
0
0
0
Cash From (Repurchase of) Equity
-32
-8
-44
-86
30
-107
-41
-62
-137
Increase in Capital Stock
44
6
29
24
32
20
24
15
14
Decrease in Capital Stock
-76
-15
-73
-110
-2
-127
-66
-76
-152
Other Financing Activities
-29
0
2
-4
-2
-4
-15
20
-11
Net Cash From Discontinued Operations (financing)
0
-2
-3
-2
0
0
0
0
0
Cash from Financing Activities
-101
2
-218
397
-44
-154
31
-107
-115
Net Cash Before Disc. Operations and FX
-19
-3
266
-288
93
33
17
79
135
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-19
-3
266
-288
93
33
17
79
135
Effect of Foreign Exchange Rates
-5
3
-1
10
1
-1
-15
-16
-13
Net Changes in Cash
-24
1
265
-278
95
32
2
63
121
Remarks
restated on Mar 1, 2011 n/a
calculated values,
restated on Feb 28, 2012 n/a
calculated values,
restated on Feb 26, 2013 n/a
calculated values,
restated on Feb 25, 2014 n/a
calculated values,
restated on Feb 24, 2015 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo